Trial Details
Not RecruitingBasic Information
| Clinical ID | c3042 |
|---|---|
| Identifier | IRCT201410062709N30 |
| Trial Title | The effect of urtica dioica leaf extract on tumor necrosis factor alpha, high- sensitivity C- reactive protein, superoxide dismutase, erythrocyte sedimentation rate, blood cell count, calprotectin and quality of life in patient with inflammatory bowel disease compared with the control group that received placebo |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel disease. Crohn disease of small intestine, Ulcerative colitis;K50, K51;Crohn disease of small intestine, Ulcerative colitis |
| Interventions | Intervention 1: Stinging nettle tablet, produced in the company of barijessence, 400 mg tablet, three times a day for 3 months in intervention group. Intervention 2: Placebo, tablets containing starch, produced in Tehran University of Medical Sciences, 400 mg tablet, three times a day for 3 months in control group.;Treatment - Drugs;Placebo;Stinging nettle tablet, produced in the company of barijessence, 400 mg tablet, three times a day for 3 months in intervention group;Placebo, tablets containing starch, produced in Tehran University of Medical Sciences, 400 mg tablet, three times a day for 3 months in control group. |
Participant Information
| Sponsor | Vice chancellor for research, Iran University of Medical Sciences |
|---|---|
| City | - |
| Country/Region | Iran |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |